DK3368017T3 - Optimeret mesalazinholdig højdosistablet - Google Patents
Optimeret mesalazinholdig højdosistablet Download PDFInfo
- Publication number
- DK3368017T3 DK3368017T3 DK16787790.1T DK16787790T DK3368017T3 DK 3368017 T3 DK3368017 T3 DK 3368017T3 DK 16787790 T DK16787790 T DK 16787790T DK 3368017 T3 DK3368017 T3 DK 3368017T3
- Authority
- DK
- Denmark
- Prior art keywords
- mesalazine
- optimized
- high dose
- containing high
- dose tablet
- Prior art date
Links
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 title 1
- 229960004963 mesalazine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15192269.7A EP3162362A1 (de) | 2015-10-30 | 2015-10-30 | Optimierte mesalazinhaltige hochdosistablette |
| PCT/EP2016/075427 WO2017072050A1 (de) | 2015-10-30 | 2016-10-21 | Optimierte mesalazinhaltige hochdosistablette |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3368017T3 true DK3368017T3 (da) | 2019-12-16 |
Family
ID=54476727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16787790.1T DK3368017T3 (da) | 2015-10-30 | 2016-10-21 | Optimeret mesalazinholdig højdosistablet |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US11135159B2 (da) |
| EP (2) | EP3162362A1 (da) |
| JP (1) | JP6872135B2 (da) |
| KR (1) | KR102701506B1 (da) |
| CN (2) | CN108348472A (da) |
| AU (1) | AU2016347352B2 (da) |
| CA (1) | CA3001435A1 (da) |
| CY (1) | CY1122473T1 (da) |
| DK (1) | DK3368017T3 (da) |
| EA (1) | EA201890828A1 (da) |
| ES (1) | ES2761319T3 (da) |
| HK (1) | HK1255193A1 (da) |
| HR (1) | HRP20192184T1 (da) |
| HU (1) | HUE046593T2 (da) |
| LT (1) | LT3368017T (da) |
| MX (1) | MX2018005358A (da) |
| PL (1) | PL3368017T3 (da) |
| PT (1) | PT3368017T (da) |
| RS (1) | RS59748B1 (da) |
| SI (1) | SI3368017T1 (da) |
| WO (1) | WO2017072050A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITUA20162293A1 (it) * | 2016-04-05 | 2017-10-05 | Sofar Spa | Processo per formulazioni solide di mesalazina |
| TR201722039A2 (tr) * | 2017-12-27 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Mesalazi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari |
| EP3662895A1 (en) * | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | A process for manufacturing reducing sugar-free 5-asa tablet cores |
| IT201800011120A1 (it) | 2018-12-14 | 2020-06-14 | Dpl Pharma S P A | Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati |
| KR102104507B1 (ko) * | 2019-08-23 | 2020-04-24 | 브릿지바이오테라퓨틱스(주) | 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법 |
| WO2022047730A1 (en) * | 2020-09-04 | 2022-03-10 | Shanghai Pharmaceuticals Holding Co., Ltd. | Methods to treat inflammatory bowel disease |
| CN115957330B (zh) * | 2022-12-16 | 2025-05-02 | 扬子江药业集团有限公司 | 一种肠溶层及其制备方法、口服制剂 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3151196A1 (de) | 1981-12-23 | 1983-06-30 | Kurt Heinz Prof. Dr. 7800 Freiburg Bauer | Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen |
| US5686105A (en) * | 1993-10-19 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| DE19732903A1 (de) | 1997-07-30 | 1999-02-04 | Falk Pharma Gmbh | Pellet-Formulierung zur Behandlung des Intestinaltraktes |
| JP2002535353A (ja) * | 1999-01-29 | 2002-10-22 | ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク | 医薬品組成物 |
| ITMI991316A1 (it) | 1999-06-14 | 2000-12-14 | Cip Ninety Two 92 S A | Composizioni farmaceutiche orali a rilascio modificato di mesalazina |
| US20030114527A1 (en) * | 2001-08-31 | 2003-06-19 | Karnachi Anees Abdulquadar | Pharmaceutical composition |
| CA2444814C (en) * | 2001-10-24 | 2009-06-09 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
| DE60133319T3 (de) * | 2001-11-23 | 2021-08-05 | Allergan pharmaceuticals International Ltd. | Mehrfach beschichete pharmazeutische dosierungsform |
| EP1519717B1 (en) * | 2002-07-05 | 2010-09-29 | Temrel Limited | Controlled release composition |
| EP1615619A2 (en) | 2003-04-23 | 2006-01-18 | Ferring B.V. | Sachet for a pharmaceutical composition |
| MY157620A (en) * | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
| JP2011500553A (ja) * | 2007-10-10 | 2011-01-06 | ルピン・リミテッド | ５−アミノサリチル酸またはその塩もしくは代謝産物の新規な結腸を標的とする調節放出性生体接着性製剤 |
| US20090162434A1 (en) * | 2007-12-21 | 2009-06-25 | Disphar International Bv | Mesalazine tablet |
| CN102036658A (zh) * | 2008-05-23 | 2011-04-27 | 香港大学 | 治疗流感的联合疗法 |
| US9463163B2 (en) * | 2009-10-16 | 2016-10-11 | Sun Pharmaceutical Industries Limited | Delayed release pharmaceutical composition of mesalamine |
| EP2425826A1 (en) * | 2010-09-01 | 2012-03-07 | Disphar International B.V. | Mesalazine tablet having improved dissolution |
| EP2468264A1 (en) * | 2010-12-27 | 2012-06-27 | Laboratorios Liconsa, S.A. | Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it |
| CN105025888B (zh) * | 2013-02-22 | 2018-10-12 | 志瑞亚新药工业株式会社 | 肠溶片 |
| EP3542791A1 (en) * | 2013-10-29 | 2019-09-25 | Tillotts Pharma AG | A delayed release drug formulation |
| IN2014MU00097A (da) * | 2014-01-10 | 2015-08-21 | Cadila Healthcare Ltd |
-
2015
- 2015-10-30 EP EP15192269.7A patent/EP3162362A1/de not_active Withdrawn
-
2016
- 2016-10-21 HR HRP20192184TT patent/HRP20192184T1/hr unknown
- 2016-10-21 EP EP16787790.1A patent/EP3368017B1/de active Active
- 2016-10-21 PT PT167877901T patent/PT3368017T/pt unknown
- 2016-10-21 EA EA201890828A patent/EA201890828A1/ru unknown
- 2016-10-21 JP JP2018521361A patent/JP6872135B2/ja active Active
- 2016-10-21 SI SI201630529T patent/SI3368017T1/sl unknown
- 2016-10-21 HU HUE16787790A patent/HUE046593T2/hu unknown
- 2016-10-21 US US15/770,569 patent/US11135159B2/en active Active
- 2016-10-21 ES ES16787790T patent/ES2761319T3/es active Active
- 2016-10-21 PL PL16787790T patent/PL3368017T3/pl unknown
- 2016-10-21 DK DK16787790.1T patent/DK3368017T3/da active
- 2016-10-21 CN CN201680062411.0A patent/CN108348472A/zh active Pending
- 2016-10-21 CN CN202311014678.0A patent/CN117180218A/zh active Pending
- 2016-10-21 AU AU2016347352A patent/AU2016347352B2/en active Active
- 2016-10-21 KR KR1020187015209A patent/KR102701506B1/ko active Active
- 2016-10-21 HK HK18114316.8A patent/HK1255193A1/zh unknown
- 2016-10-21 MX MX2018005358A patent/MX2018005358A/es active IP Right Grant
- 2016-10-21 WO PCT/EP2016/075427 patent/WO2017072050A1/de not_active Ceased
- 2016-10-21 RS RS20191673A patent/RS59748B1/sr unknown
- 2016-10-21 CA CA3001435A patent/CA3001435A1/en active Pending
- 2016-10-21 LT LTEP16787790.1T patent/LT3368017T/lt unknown
-
2019
- 2019-12-20 CY CY20191101366T patent/CY1122473T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3368017A1 (de) | 2018-09-05 |
| CN108348472A (zh) | 2018-07-31 |
| PT3368017T (pt) | 2020-01-06 |
| ES2761319T3 (es) | 2020-05-19 |
| KR102701506B1 (ko) | 2024-09-02 |
| MX2018005358A (es) | 2018-06-06 |
| SI3368017T1 (sl) | 2020-01-31 |
| HK1255193A1 (zh) | 2019-08-09 |
| US11135159B2 (en) | 2021-10-05 |
| CA3001435A1 (en) | 2017-05-04 |
| US20180311155A1 (en) | 2018-11-01 |
| JP2018531960A (ja) | 2018-11-01 |
| HRP20192184T1 (hr) | 2020-03-06 |
| KR20180077246A (ko) | 2018-07-06 |
| EP3162362A1 (de) | 2017-05-03 |
| CY1122473T1 (el) | 2021-01-27 |
| CN117180218A (zh) | 2023-12-08 |
| AU2016347352A1 (en) | 2018-05-10 |
| EP3368017B1 (de) | 2019-11-06 |
| PL3368017T3 (pl) | 2020-04-30 |
| EA201890828A1 (ru) | 2018-11-30 |
| LT3368017T (lt) | 2020-01-27 |
| RS59748B1 (sr) | 2020-02-28 |
| AU2016347352B2 (en) | 2021-09-09 |
| JP6872135B2 (ja) | 2021-05-19 |
| WO2017072050A1 (de) | 2017-05-04 |
| HUE046593T2 (hu) | 2020-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3328880T3 (da) | Terapeutiske midler | |
| DK3265421T3 (da) | Doseringssystem | |
| HUE058677T2 (hu) | Meloxicamot tartalmazó gyógyászati készítmény | |
| HUE054344T2 (hu) | Gyógyászati készítmények AZD9291 tartalommal | |
| DK3259015T3 (da) | Bioelektroniske lægemidler | |
| HUE045234T2 (hu) | Gyógyszeradagolás tanulása | |
| HUE043290T2 (hu) | Adagoló kapszula | |
| DK3283058T3 (da) | Ribociclib-tablet | |
| EP3689892A4 (en) | RADIOACTIVE MEDICINAL PRODUCT | |
| DK3368017T3 (da) | Optimeret mesalazinholdig højdosistablet | |
| SG11201800591TA (en) | Tablet | |
| DK3189891T3 (da) | Kombinationstabletmaskine | |
| UA31197S (uk) | Таблетка | |
| EP3341117C0 (en) | Reactor | |
| EP3246047C0 (en) | COMBINATION MEDICATION | |
| LT3383385T (lt) | Melflufeno dozavimo režimas vėžio atveju | |
| KR20180084810A (ko) | 정제 세트 | |
| DK3280447T3 (da) | Farmaceutiske formuleringer | |
| EP3395344A4 (en) | MEDICINE | |
| EP3217965C0 (en) | Pharmaceutical processing | |
| IL249374A0 (en) | Pharmaceutical administration forms | |
| DK3288967T3 (da) | Farmaceutisk forbindelse | |
| GB201511252D0 (en) | Tablet | |
| MA41359A (fr) | Comprimé optimisé a une haute dose contenant de la mesalazine | |
| CL2017002185S1 (es) | Tableta farmacéutica |